Merck says experimental Hepatitis C treatment shows 95% cure rate By: MarketWatch April 24, 2015 at 07:34 AM EDT Company remains on track to submit New Drug Application to FDA in first half of this year. Read More >> Related Stocks: Gilead Sciences Merck & Co